Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT06603870

Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

Led by Ottawa Hospital Research Institute · Updated on 2025-05-30

330

Participants Needed

1

Research Sites

249 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This trial seeks to evaluate a management strategy after the acute treatment duration (≥ 3 months of therapeutic anticoagulation) for patients with cancer and catheter-related upper extremity deep vein thrombosis (DVT).

CONDITIONS

Official Title

Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years or older with active cancer diagnosed or treated within 6 months, or with metastatic, recurrent, progressive, or hematological malignancy not in complete remission
  • Objectively confirmed catheter-related upper extremity deep vein thrombosis treated with standard therapeutic anticoagulation for at least 3 months
  • Able and willing to provide informed consent
Not Eligible

You will not qualify if you...

  • Active bleeding or other contraindications to anticoagulation
  • Need for ongoing therapeutic anticoagulation for other medical reasons such as atrial fibrillation or mechanical heart valve
  • Anticoagulation permanently stopped or reduced to prophylactic dose before enrollment, except for brief transition to apixaban dosing as per protocol
  • Known allergy, hypersensitivity, or pregnancy contraindicating apixaban use
  • Use of strong inhibitors or inducers of both cytochrome P450 3A4 and P-glycoprotein

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Ottawa Hospital

Ottawa, Ontario, Canada, K1H 8L6

Actively Recruiting

Loading map...

Research Team

T

Tzu-Fei Wang, MD, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here